Skip to main content

Loading market data...

LH

Labcorp Holdings Inc.

NYSE • United states

$324.43

+$1.30

(+0.40%)

Source: Yahoo Finance · Quote time Oct 21, 2026 18:48 GMT+0000

Management
Credibility
Score

Labcorp Holdings Inc. (LH)

Unavailable

Quotes may be delayed

$26.31B

Market Cap

286,146

Volume

26.2

P/E Ratio

0.90%

Div Yield

Labcorp Holdings Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 358 S MAIN ST, BURLINGTON, NC
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

21 Oct 2026

Labcorp Holdings Inc. reported Regulation FD disclosure

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

30 Sep 2026

Labcorp Holdings Inc. reported Regulation FD disclosure

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

22 Sep 2026

Labcorp Holdings Inc. reported Regulation FD disclosure

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure.

10 Sep 2026

Labcorp Holdings Inc. reported Regulation FD disclosure

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

28 Aug 2026

Labcorp Holdings Inc. reported Regulation FD disclosure

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$141.80M

Total assets (USD)$18.53B

Total liabilities (USD)$9.91B

Shareholders' equity (USD)$8.61B

Long-term debt (USD)$5.86B

Debt due within a year (USD)$900,000

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$3.73B	$451.60M	$298.70M	$3.64	10-Q · 5 Aug 2026
Q1 2026	$3.54B	$380.80M	$277.80M	$3.35	10-Q · 4 May 2026
Q4 2025	$3.52B	$267.60M	$165.20M	Unavailable	10-K · 24 Feb 2026
Q3 2025	$3.56B	$396.60M	$261.10M	$3.12	10-Q · 31 Oct 2025
Q2 2025	$3.53B	$394.50M	$237.90M	$2.84	10-Q · 1 Aug 2025
Q1 2025	$3.35B	$326.00M	$212.80M	$2.52	10-Q · 29 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $343.50

5.9% upside potential

📈

Strong Buy

Unavailable

👍

Buy

10

⏸️

Hold

3

📉

Sell

0

13 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 18:48 UTC Targets range 306.00–380.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

17

Aug 2026

ANDERSON KERRII B

Director

Open-market sale

$318.02 per share

3,000 shares

11

Aug 2026

Schechter Adam H

Director, President & CEO

Open-market sale

$320.37 per share

4,669 shares

4

Aug 2026

Summy Amy B.

EVP, Chief Marketing Officer

Open-market sale

$306.74 per share

924 shares

3

Aug 2026

Wilkinson Peter J

SVP, Chief Accounting Officer

Open-market sale

$309.23 per share

1,420 shares

3

Aug 2026

Wilkinson Peter J

SVP, Chief Accounting Officer

Option exercise

$209.25 per share

1,338 shares

Top Shareholders

Vanguard Group Inc

9,850,631 shares

0.379% change

12/31/2025

Blackrock, Inc.

6,574,261 shares

2.008% change

6/30/2026

Vanguard Capital Management Llc

5,362,254 shares

-0.258% change

6/30/2026

Victory Capital Management Inc

4,837,573 shares

4.548% change

6/30/2026

State Street Corp

3,907,656 shares

1.152% change

6/30/2026

Vanguard Portfolio Management Llc

3,678,798 shares

-0.051% change

6/30/2026

Boston Partners

3,051,690 shares

28.829% change

6/30/2026

Allspring Global Investments Holdings, Llc

2,236,957 shares

0.472% change

6/30/2026

Geode Capital Management, Llc

2,188,890 shares

0.135% change

6/30/2026

Select Equity Group, L.P.

1,981,948 shares

-8.867% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 18:49 UTC· 12 hours ago

Research coverage and investment tools

Labcorp Holdings Inc. (LH) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical Specialities). Its last price was US$324.43 on 21 Oct 2026. That is 82% of the way from its 52-week low of US$244.52 to its 52-week high of US$341.80. It paid US$2.88 a share in dividends over the last 12 months, a dividend yield of 0.90%. The latest ex-dividend date on file is 28 Aug 2026. Its market capitalisation was US$26.31 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$3.73B	$451.60M	$298.70M	$3.64	29.8%	12.1%	$313.90M	10-Q · 5 Aug 2026 (opens in a new tab)
Q1 2026	$3.54B	$380.80M	$277.80M	$3.35	28.7%	10.8%	$70.50M	10-Q · 4 May 2026 (opens in a new tab)
Q4 2025	$3.52B	$267.60M	$165.20M	Unavailable	28.2%	7.6%	$490.30M	10-K · 24 Feb 2026 (opens in a new tab)
Q3 2025	$3.56B	$396.60M	$261.10M	$3.12	28.8%	11.1%	$280.50M	10-Q · 31 Oct 2025 (opens in a new tab)
Q2 2025	$3.53B	$394.50M	$237.90M	$2.84	29.7%	11.2%	$542.70M	10-Q · 1 Aug 2025 (opens in a new tab)
Q1 2025	$3.35B	$326.00M	$212.80M	$2.52	28.3%	9.7%	−$107.50M	10-Q · 29 Apr 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/30/2026	$4.99	$4.79	+4.2%
Mar 2026	4/30/2026	$4.25	$4.09	+3.9%
Dec 2025	2/17/2026	$4.07	$3.95	+3.0%
Sep 2025	10/28/2025	$4.18	$4.13	+1.2%

Cash and equivalents: $141.80M
Total assets: $18.53B
Total liabilities: $9.91B
Shareholders' equity: $8.61B
Long-term debt: $5.86B
Debt due within a year: $900,000

8-K · 21 Oct 2026

Labcorp Holdings Inc. reported Regulation FD disclosure (opens in a new tab)

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 30 Sep 2026

Labcorp Holdings Inc. reported Regulation FD disclosure (opens in a new tab)

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 22 Sep 2026

Labcorp Holdings Inc. reported Regulation FD disclosure (opens in a new tab)

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure.
8-K · 10 Sep 2026

Labcorp Holdings Inc. reported Regulation FD disclosure (opens in a new tab)

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 28 Aug 2026

Labcorp Holdings Inc. reported Regulation FD disclosure (opens in a new tab)

Labcorp Holdings Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
ANDERSON KERRII B Director	17 Aug 2026	Open-market sale (S)	−3,000	$318.02	Form 4 (opens in a new tab)
Schechter Adam H Director, President & CEO	11 Aug 2026	Open-market sale (S)	−4,669	$320.37	Form 4 (opens in a new tab)
Summy Amy B. EVP, Chief Marketing Officer	4 Aug 2026	Open-market sale (S)	−924	$306.74	Form 4 (opens in a new tab)
Wilkinson Peter J SVP, Chief Accounting Officer	3 Aug 2026	Open-market sale (S)	−1,420	$309.23	Form 4 (opens in a new tab)
Wilkinson Peter J SVP, Chief Accounting Officer	3 Aug 2026	Option exercise (M)	+1,338	$209.25	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	9,850,631	0.379%
Blackrock, Inc.	6/30/2026	6,574,261	2.008%
Vanguard Capital Management Llc	6/30/2026	5,362,254	-0.258%
Victory Capital Management Inc	6/30/2026	4,837,573	4.548%
State Street Corp	6/30/2026	3,907,656	1.152%
Vanguard Portfolio Management Llc	6/30/2026	3,678,798	-0.051%
Boston Partners	6/30/2026	3,051,690	28.829%
Allspring Global Investments Holdings, Llc	6/30/2026	2,236,957	0.472%
Geode Capital Management, Llc	6/30/2026	2,188,890	0.135%
Select Equity Group, L.P.	6/30/2026	1,981,948	-8.867%

Previous close: 323.13 USD
Day range: 317.71 – 324.98 USD
52-week range: 244.52 – 341.80 USD
Volume: 286,146
Market cap: $26.31B
Average volume: 764,798
P/E ratio: 26.2
EPS (FY 2025, diluted): 10.46 USD
Dividends (last 12 months): 2.88 USD
Dividend yield: 0.90%
Ex-dividend date: 28 Aug 2026
Shares outstanding: 81.10M
Beta (5Y monthly): 0.90

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 18:48 UTC· 12 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:33 UTC· 39 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:33 UTC· 39 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for LH yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.